Dirk Schürmann Selected Research

Dirk Schürmann Research Topics

Disease

8	Infections 01/2022 - 12/2004
5	HIV Infections (HIV Infection) 01/2017 - 10/2006
3	Disease Progression 08/2020 - 05/2006
3	Acquired Immunodeficiency Syndrome (AIDS) 11/2019 - 10/2007
3	Hepatitis B 10/2006 - 08/2002
1	Hypernatremia 06/2021
1	Cholangitis 06/2021
1	Cysts 06/2021
1	Lung Diseases (Lung Disease) 04/2021
1	Blister (Bulla) 02/2021
1	Erythema Multiforme 02/2021
1	COVID-19 08/2020
1	Headache (Headaches) 01/2020
1	Neoplasms (Cancer) 12/2019
1	Pleural Effusion (Pleural Effusions) 12/2019
1	Encephalitis (Encephalitis, Rasmussen) 11/2019
1	Toxoplasmosis 11/2019
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 11/2019
1	Immune Reconstitution Inflammatory Syndrome 11/2019
1	Hepatitis C 01/2016
1	Emphysema 01/2016
1	Herpes Zoster 04/2015
1	Inflammation (Inflammations) 03/2014
1	Lymphopenia (Lymphocytopenia) 06/2013
1	Mannose-Binding Protein Deficiency 06/2013
1	Hodgkin Disease (Hodgkin's Disease) 11/2012
1	Coinfection 01/2010
1	Liver Diseases (Liver Disease) 01/2010
1	Soft Tissue Infections 02/2009
1	Syphilis 01/2009
1	Virus Diseases (Viral Diseases) 10/2007
1	Chronic Hepatitis B 10/2006
1	Nausea 05/2006
1	Drug Hypersensitivity (Drug Allergy) 05/2006
1	Diarrhea 05/2006
1	Pneumonia (Pneumonitis) 12/2005
1	Lipodystrophy 11/2005
1	Lipomatosis 11/2005

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2020 - 05/2006
3	NucleosidesIBA 01/2022 - 11/2019
3	AntigensIBA 01/2022 - 10/2006
3	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2006
3	Ritonavir (Norvir)FDA Link 11/2019 - 05/2006
3	Lamivudine (Epivir)FDA Link 10/2006 - 08/2002
3	Tenofovir (Viread)FDA Link 10/2006 - 08/2002
2	Antiviral Agents (Antivirals)IBA 01/2022 - 05/2006
2	Reverse Transcriptase InhibitorsIBA 01/2022 - 11/2019
2	PerforinIBA 02/2021 - 01/2017
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2010 - 05/2006
2	Enfuvirtide (Fuzeon)FDA Link 12/2007 - 10/2007
2	Proteins (Proteins, Gene)FDA Link 12/2007 - 10/2007
1	ulonivirineIBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	Praziquantel (Biltricide)FDA Link 06/2021
1	Albendazole (Albenza)FDA Link 06/2021
1	GlucocorticoidsIBA 04/2021
1	Heme (Haem)IBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	islatravirIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 11/2019
1	EnzymesIBA 01/2016
1	VaccinesIBA 04/2015
1	IntegrinsIBA 03/2014
1	Phenobarbital (Luminal)FDA Link 03/2014
1	AntibodiesIBA 06/2013
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 06/2013
1	ProdrugsIBA 10/2012
1	fostemsavirIBA 10/2012
1	BMS-626529IBA 10/2012
1	vicrivirocIBA 01/2010
1	Vancomycin FDA LinkGeneric 02/2009
1	Linezolid (Zyvox)FDA Link 02/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	Hepatitis B virus P proteinIBA 10/2006
1	Triglycerides (Triacylglycerol)IBA 05/2006
1	Nelfinavir (Viracept)FDA Link 05/2006
1	lamivudine drug combination abacavir FDA Link 05/2006
1	fosamprenavir (Lexiva)FDA Link 05/2006
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2005
1	Erythromycin (Erycette)FDA LinkGeneric 12/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2005
1	Third Generation CephalosporinsIBA 12/2005
1	Moxifloxacin (Avelox)FDA Link 12/2005
1	FluoroquinolonesIBA 12/2005
1	adefovir dipivoxil (Hepsera)FDA Link 12/2004
1	adefovirIBA 12/2004

Therapy/Procedure

8	Therapeutics 11/2019 - 12/2005
3	Highly Active Antiretroviral Therapy (HAART) 04/2014 - 11/2005
2	Catheters 06/2021 - 12/2019
2	Art Therapy 11/2019 - 04/2015
1	Punctures 06/2021
1	Pleurodesis 12/2019
1	Transplantation 06/2013